SLC26A3 Antikörper (C-Term)
Kurzübersicht für SLC26A3 Antikörper (C-Term) (ABIN7184835)
Target
Alle SLC26A3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human DRA.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:2000, ELISA:1:20000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- SLC26A3 (Solute Carrier Family 26, Member 3 (SLC26A3))
-
Andere Bezeichnung
- SLC26A3
-
Hintergrund
- Chloride anion exchanger antibody, CLD antibody, Congenital chloride diarrhea antibody, Down regulated in adenoma antibody, Down regulated in adenoma protein antibody, Down-regulated in adenoma antibody, DRA antibody, Protein DRA antibody, S26A3_HUMAN antibody, SLC26A3 antibody, Solute carrier family 26 member 3 antibody
-
UniProt
- P40879
Target
-